Mann Fung

Dr. Mann Fung was VP Oncology Scientific Innovation at Johnson & Johnson Innovation Centre, Asia Pacific, responsible for creating and implementing an external innovation plan focused on developing an industry-leading portfolio of oncology investment opportunities in Asia Pacific. Previously, Dr. Fung was Vice President, Compound Development Team Leader at Janssen. He was also the Executive Director/Head of Specialty Pharma Development at McNeil. Prior to joining Johnson & Johnson, Dr. Fung was Head of Oncology & Critical Care at Eli Lilly Japan and a Team Leader and Reviewer at the FDA.